Resultats de la cerca - Ulf Aasebø

  • Mostrar 1 - 10 resultats de 10
Refinar resultats
  1. 1
    The Diagnosis of Adult Pneumonia in General Practice:<i>The Diagnostic Value of History, Physical Examination and Some Blood Tests</i>

    The Diagnosis of Adult Pneumonia in General Practice:<i>The Diagnostic Value of History, Physical Examination and Some Blood Tests</i> per Hasse Melbye, Bjørn Straume, Ulf Aasebø, Jan Brox

    Publicat 1988
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Low oxygen saturation and mortality in an adult cohort: the Tromsø study

    Low oxygen saturation and mortality in an adult cohort: the Tromsø study per Monica Linea Vold, Ulf Aasebø, Tom Wilsgaard, Hasse Melbye

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial

    Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial per Johan Svartberg, Ulf Aasebø, Audhild Hjalmarsen, Johan Sundsfjord, Rolf Jorde

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group

    Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung... per Hans H. Strøm, Roy M. Bremnes, Stein Sundstrøm, Nina Helbekkmo, Øystein Fløtten, Ulf Aasebø

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer

    Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer per Christian von Plessen, Bengt Bergman, Olga Andresen, R. M. Bremnes, Stein Sundstrøm, M Gilleryd, RJ Stephens, Jan Vilsvik, Ulf Aasebø, S Sörenson

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity

    Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity per Nina Helbekkmo, Stein Sundstrøm, Ulf Aasebø, Paal Brunsvig, Christian von Plessen, Harald Hjelde, Oddveig K. Garpestad, Abigail Bailey, Roy M. Bremnes

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Hypofractionated Palliative Radiotherapy (17 Gy per two fractions) in Advanced Non–Small-Cell Lung Carcinoma Is Comparable to Standard Fractionation for Symptom Control and Survival: A National Phase III Trial

    Hypofractionated Palliative Radiotherapy (17 Gy per two fractions) in Advanced Non–Small-Cell Lung Carcinoma Is Comparable to Standard Fractionation for Symptom Control and Surviva... per Stein Sundstrøm, Roy M. Bremnes, Ulf Aasebø, Steinar Aamdal, Reidulv Hatlevoll, Paal Brunsvig, Dag Clement Johannessen, Olbjørn Klepp, Peter Fayers, Stein Kaasa

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial

    Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial per Andreas Hermes, Bengt Bergman, Roy M. Bremnes, Lars Ek, Sverre Fluge, Christer Sederholm, Stein Sundstrøm, Lars Thaning, Jan Vilsvik, Ulf Aasebø, Sverre Sörenson

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer

    Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non–Small-Ce... per Bjørn Henning Grønberg, Roy M. Bremnes, Øystein Fløtten, Tore Amundsen, Paal Brunsvig, Harald Hjelde, Stein Kaasa, Christian von Plessen, Frøydis Stornes, Terje Tollåli, Finn Wammer, Ulf Aasebø, Stein Sundstrøm

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer

    Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer per Bjørn Henning Grønberg, Tarje Onsøien Halvorsen, Øystein Fløtten, Odd Terje Brustugun, Paal Brunsvig, Ulf Aasebø, Roy M. Bremnes, Terje Tollåli, Kjersti Hornslien, Bjørg Y. Aksnessæther, Erik Dyb Liaaen, Stein Sundstrøm

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: